Navigation Links
Pharmasset Prices Public Offering of Common Stock
Date:1/21/2011

PRINCETON, N.J., Jan. 21, 2011 /PRNewswire/ -- Pharmasset, Inc. (Nasdaq: VRUS) announced today the pricing of an underwritten public offering of 3,300,000 shares of its common stock at an offering price of $46.33 per share.  Of the shares being sold, Pharmasset is selling 2,300,000 shares and the selling stockholders are selling 1,000,000 shares.  Pharmasset expects to receive net proceeds, after deducting the underwriting discount and estimated offering expenses, of approximately $101.5 million.  Pharmasset will not receive any proceeds from the sale of shares by the selling stockholders.  In addition, Pharmasset has granted the underwriters a 30-day option to purchase up to an additional 495,000 shares of common stock. The offering is expected to close on January 26, 2011, subject to customary closing conditions. Citi is serving as sole book-running manager for the offering. Morgan Stanley & Co. Incorporated is serving as the co-lead manager, and BofA Merrill Lynch, Leerink Swann LLC and Wedbush PacGrow Life Sciences are serving as co-managers.

The shares described above are being offered pursuant to an automatic shelf registration statement filed by Pharmasset with the Securities and Exchange Commission on January 18, 2011, which became effective upon filing.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Copies of the prospectus supplement and accompanying base prospectus relating to this offering may be obtained from Citi at Brooklyn Army Terminal, 140 58th Street, 8th Floor, Brooklyn, NY 11220, Attention: Prospectus D
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmasset Announces Proposed Public Offering of Common Stock
2. Pharmasset Reports Positive Results from its HCV Clinical Programs
3. Pharmasset to Present at the 29th Annual J.P. Morgan Healthcare Conference
4. Pharmasset Initiates Exploratory Interferon Sparing Clinical Trial of PSI-7977 for Chronic Hepatitis C
5. Pharmasset to Webcast an Investor Event from the AASLD Meeting
6. Pharmasset to Present at the JMP Healthcare Conference
7. Pharmasset to Present at the UBS Global Life Sciences Conference
8. Pharmasset Initiates Phase 2b Clinical Trial of PSI-7977 for Chronic Hepatitis C Genotypes 1, 2, and 3
9. Pharmasset to Present at the 28th Annual JPMorgan Healthcare Conference
10. Pharmasset Reports Fiscal Year End 2009 Financial Results
11. Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015  BioLife Solutions, Inc. (NASDAQ: BLFS ), a ... hypothermic storage and cryopreservation freeze media and ... ("BioLife" or the "Company"), announced that the Company is scheduled ... The Company is scheduled to present at the Conference ... the Grand Hyatt Hotel in New York City ...
(Date:5/22/2015)... , May 22, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... protection, repair and regeneration, today announced that J.J. ... to present a corporate overview at two upcoming investor ... the SeeThruEquity 4 th Annual Microcap Conference on ... City at 11:00 am EDT.  A webcast ...
(Date:5/22/2015)... , May 22, 2015 According ... Market by Product (Consumables, Instruments, Services), by Test Type ... Chromatography, Flow Cytometry), by End Users - Global Forecast ... Market is expected to reach $736.85 Million by 2020 ... of 10.25%. Browse 71 market data ...
Breaking Medicine Technology:BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 4
... BOULDER, Colo. and MONTREAL, Feb. 14 Pharmion,Corporation ... MYG) today announced,that the U.S. Food and Drug ... inhibitor, MGCD0103, as an Orphan,Drug for the treatment ... Criteria for designation require that the product be ...
... Australia, Feb. 13 Progen,Pharmaceuticals Limited (ASX: ... results from a phase 2 investigator-initiated trial ... Taxotere(R),(docetaxel) administered to patients with prostate cancer. ... Haematology and Oncology Clinics, the,principal investigator conducting ...
Cached Medicine Technology:Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 2Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 3Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 4Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium 2Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium 3
(Date:5/22/2015)... The dentist in West ... they are now offering complimentary consultations to patients ... At consultations, patients can discuss their candidacy for ... treatments can achieve and whether alternative options are ... appointment. If treatments are chosen, patients can start ...
(Date:5/22/2015)... May 22, 2015 sweetFrog Enterprises, LLC. is ... Jacksonville, Texas. Jacksonville is now the 16th sweetFrog store located ... was listed as #22 on the Inc. 500 list of ... lived and worked in East Texas for 20 years and ... owner of the Jacksonville, and nearby Palestine, sweetFrog locations. “We ...
(Date:5/22/2015)... DMG Productions announces the upcoming airing of Innovations ... May 29, 2015 at 7:30 a.m. ET and 7:30 ... Innovations will explore Interstate Restoration, a company dedicated to ... recovery and restoration. , Additionally, the series will focus ... and deliver training and education in the areas of ...
(Date:5/22/2015)... York, NY (PRWEB) May 22, 2015 ... Multifamily Housing, Marc Zuluaga, has been selected by Consulting-Specifying ... engineering. The award winners are featured in the May/June ... to 40 building industry professionals age 40 and younger ... the building community, as well as in other areas ...
(Date:5/22/2015)... A new program for the "In America" ... of Physical Therapy. , James Earl Jones will ... of physical therapy and discusses how the exercises can ... variety of ailments and injuries. Physical therapists work ... that enhances daily activities such as house cleaning and ...
Breaking Medicine News(10 mins):Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:sweetFrog Opens New Location in Jacksonville, Texas 2Health News:New Episode of Innovations Airing Friday, May 29, 2015 Via Discovery Channel 2Health News:Steven Winter Associates’ Marc Zuluaga Earns Innovative Engineering Award 2
... 2 Mylan Inc. (NYSE: MYL ),today announced ... Asia Pacific following the completion of Mylan,s acquisition of,Merck,s ... over 30 years in the pharmaceuticals,industry and has extensive ... UK, U.S. and Asia Pacific regions. At Merck,Generics, he ...
... Mylan Inc. (NYSE: MYL ),today announced the ... (Europe, Middle East and Africa) following the completion,of Mylan,s ... Generics, M. Barret most recently served as Region Director,EMEA, ... position in 2004,following his role as Area Director for ...
... in obstetrics and ... emergency departments., CHICAGO, Oct. 2 ... according to the Aon Corporation 2007,Hospital Professional Liability and Physician Liability ... liability,claims in the U.S. health care industry, is published by Aon ...
... One recommendation: MRIs, other scans aren,t always helpful , TUESDAY, ... order MRIs, CT scans and other diagnostic tests for patients ... released by the American College of Physicians and the American ... Oct. 2 issue of the journal Annals of Internal ...
... effects impacting cognition don,t end with the last dose ... cognitive impairment experienced by 14 to 45 percent of ... personal and professional lives. Patients report that the lack ... and the inability to organize or multi-task have led ...
... Holding, Inc. (OTCBB: MITD - News), has signed an ... stop the spread of infectious diseases. Dr. Thomas ... Director of the Biodefense and Infectious Disease Laboratory and ... of Public Health, Georgia Southern University, will oversee the ...
Cached Medicine News:Health News:Mylan Announces Appointment of John Montgomery as President, Asia Pacific 2Health News:Mylan Announces Appointment of Didier Barret as President, Europe, Middle East and Africa 2Health News:Aon Corporation Study Finds Hospital Claims at New Lows 2Health News:Aon Corporation Study Finds Hospital Claims at New Lows 3Health News:Aon Corporation Study Finds Hospital Claims at New Lows 4Health News:Aon Corporation Study Finds Hospital Claims at New Lows 5Health News:Experts Issue Guidelines on Treating Low Back Pain 2Health News:Cognitive deficits lead to 'loss of self' among cancer patients 2
Used in conjunction with the E5381 700 Circling Band (240 style). Indications: When high buckle is required. Overall length: 11.6 mm....
Asymmetrical concave inner surface to conform to globe. Used in conjunction with the E5381 700 Circling Band (240 style). Indications: Wide scleral bed. Outside diameter 31.7 mm....
Concave inner surface to conform to the globe. Used in conjunction with the E5381 600 Circling Band (240 style). Indications: Wide scleral bed. Outside diameter 31.7 mm....
Used in conjunction with the E5381 700 Circling Band (240 style). Indications: Narrow scleral bed. Overall length: 100 mm, 3.9 inches....
Medicine Products: